Compare Stocks

Comparative Price Performance Over Time

Compare Stocks - Price & Volume

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
$1.87
-5.1%
$1.98
$1.03
$2.85
$310.48M0.981.72 million shs842,714 shs
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
$0.38
-2.6%
$0.35
$0.29
$1.06
$11.50M0.91119,726 shs235,069 shs
Emmis Communications Co. stock logo
EMMS
Emmis Communications
$4.82
$1.53
$1.33
$2.39
$64.12M1.0118,209 shsN/A
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
$1.26
-4.5%
$1.51
$0.55
$3.60
$31.39M1.1454,700 shs73,226 shs
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
$23.46
+3.0%
$25.87
$15.30
$36.84
$253.37M2.34120,474 shs121,708 shs
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
-5.08%-5.56%+12.65%+7.47%+0.54%
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
-1.56%+9.00%+11.31%-12.06%-63.20%
Emmis Communications Co. stock logo
EMMS
Emmis Communications
0.00%0.00%+0.42%-8.19%+48.31%
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
-4.55%-3.82%-10.00%-30.39%-49.40%
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
+2.99%+5.91%+1.56%-27.03%+13.61%

MarketRank™

CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
2.8697 of 5 stars
3.53.00.00.03.22.50.6
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
1.9823 of 5 stars
0.05.00.00.02.93.30.6
Emmis Communications Co. stock logo
EMMS
Emmis Communications
N/AN/AN/AN/AN/AN/AN/AN/A
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
N/AN/AN/AN/AN/AN/AN/AN/A
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
3.2746 of 5 stars
3.53.00.00.02.60.82.5

Analyst Ratings

CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
3.00
Buy$10.50461.50% Upside
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
N/AN/AN/AN/A
Emmis Communications Co. stock logo
EMMS
Emmis Communications
N/AN/AN/AN/A
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
N/AN/AN/AN/A
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
3.00
Buy$38.0061.98% Upside

Current Analyst Ratings

Latest CTHR, EMMS, JAKK, GLXZ, and ATAI Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
4/4/2024
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
Cantor Fitzgerald
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight
4/3/2024
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
Maxim Group
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeHold ➝ Buy$6.00
4/3/2024
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$20.00 ➝ $15.00
4/1/2024
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
Ascendiant Capital Markets
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetBuy ➝ Buy$41.00 ➝ $38.00
3/27/2024
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$20.00
(Data available from 4/25/2021 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Sales & Book Value

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
$310K1,001.54N/AN/A$1.47 per share1.27
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
$29.95M0.38N/AN/A$1.30 per share0.29
Emmis Communications Co. stock logo
EMMS
Emmis Communications
$114.13M0.56$7.30 per share0.66$7.69 per share0.63
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
$27.79M1.13$0.09 per share14.61($0.74) per share-1.70
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
$711.56M0.36$5.61 per share4.18$18.87 per share1.24

Profitability & Earnings

CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
-$40.22M-$0.29N/AN/AN/A-12,810.51%-45.08%-38.46%5/9/2024 (Estimated)
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
-$19.58M-$0.75N/AN/A-91.98%-57.44%-46.97%5/2/2024 (Confirmed)
Emmis Communications Co. stock logo
EMMS
Emmis Communications
$23.35MN/A1.02N/A85.66%-10.85%-4.65%N/A
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
-$1.81M-$0.08N/AN/A-6.50%N/A-4.43%N/A
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
$38.41M$3.416.885.55N/A5.24%24.69%10.45%N/A

Latest CTHR, EMMS, JAKK, GLXZ, and ATAI Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/2/2024N/A
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
N/AN/AN/AN/AN/AN/A  
3/28/2024Q4 2023
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
-$0.17-$0.12+$0.05-$0.12$0.90 million$0.02 million
3/22/2024Q4 2023
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
N/A-$0.03-$0.03-$0.03N/A$6.74 million
2/29/2024Q4 2023
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
-$0.74-$1.21-$0.47-$1.30$136.54 million$127.40 million
2/13/2024Q2 2024
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
N/A-$0.09-$0.09-$0.09N/A$7.91 million

Dividends

CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
N/AN/AN/AN/AN/A
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
N/AN/AN/AN/AN/A
Emmis Communications Co. stock logo
EMMS
Emmis Communications
N/AN/AN/AN/AN/A
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
N/AN/AN/AN/AN/A
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
N/AN/AN/AN/AN/A

Debt

CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
0.08
9.22
9.22
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
N/A
2.84
1.65
Emmis Communications Co. stock logo
EMMS
Emmis Communications
0.57
3.17
3.17
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
N/A
4.54
4.54
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
N/A
1.71
1.36

Ownership

Institutional Ownership

CompanyInstitutional Ownership
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
28.41%
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
23.59%
Emmis Communications Co. stock logo
EMMS
Emmis Communications
35.72%
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
0.43%
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
44.38%

Miscellaneous

CompanyEmployeesShares OutstandingFree FloatOptionable
Atai Life Sciences stock logo
ATAI
Atai Life Sciences
133166.03 million116.22 millionOptionable
Charles & Colvard, Ltd. stock logo
CTHR
Charles & Colvard, Ltd.
4830.34 million22.88 millionNot Optionable
Emmis Communications Co. stock logo
EMMS
Emmis Communications
23413.30 millionN/ANot Optionable
Galaxy Gaming, Inc. stock logo
GLXZ
Galaxy Gaming
4624.91 million19.66 millionNot Optionable
JAKKS Pacific, Inc. stock logo
JAKK
JAKKS Pacific
65910.80 million10.45 millionOptionable

CTHR, EMMS, JAKK, GLXZ, and ATAI Headlines

SourceHeadline
Jakks: Q1 Earnings SnapshotJakks: Q1 Earnings Snapshot
sfgate.com - April 24 at 7:18 PM
Jakks Pacific Shares Sink 10% After Fewer Film Releases Hit 1Q ResultsJakks Pacific Shares Sink 10% After Fewer Film Releases Hit 1Q Results
marketwatch.com - April 24 at 7:18 PM
Lacking blockbuster hits, JAKKS Pacifics sales slip 16%Lacking blockbuster hits, JAKKS Pacific's sales slip 16%
msn.com - April 24 at 7:18 PM
JAKKS Pacific Reports First Quarter 2024 Financial ResultsJAKKS Pacific Reports First Quarter 2024 Financial Results
globenewswire.com - April 24 at 4:05 PM
Jakks Pacific earnings preview: what to expectJakks Pacific earnings preview: what to expect
markets.businessinsider.com - April 24 at 2:18 PM
Investors in JAKKS Pacific (NASDAQ:JAKK) have seen solid returns of 219% over the past three yearsInvestors in JAKKS Pacific (NASDAQ:JAKK) have seen solid returns of 219% over the past three years
finance.yahoo.com - April 21 at 1:32 PM
Q3 2024 Earnings Estimate for JAKKS Pacific, Inc. Issued By Zacks Research (NASDAQ:JAKK)Q3 2024 Earnings Estimate for JAKKS Pacific, Inc. Issued By Zacks Research (NASDAQ:JAKK)
americanbankingnews.com - April 19 at 2:31 AM
3 Stock to Watch From Promising Toys & Games Industry3 Stock to Watch From Promising Toys & Games Industry
zacks.com - April 18 at 9:11 AM
Q3 2024 EPS Estimates for JAKKS Pacific, Inc. (NASDAQ:JAKK) Raised by AnalystQ3 2024 EPS Estimates for JAKKS Pacific, Inc. (NASDAQ:JAKK) Raised by Analyst
marketbeat.com - April 18 at 6:16 AM
JAKKS Pacific, Inc. (NASDAQ:JAKK) to Post Q2 2024 Earnings of $0.72 Per Share, Zacks Research ForecastsJAKKS Pacific, Inc. (NASDAQ:JAKK) to Post Q2 2024 Earnings of $0.72 Per Share, Zacks Research Forecasts
americanbankingnews.com - April 18 at 1:46 AM
Brokers Offer Predictions for JAKKS Pacific, Inc.s Q2 2024 Earnings (NASDAQ:JAKK)Brokers Offer Predictions for JAKKS Pacific, Inc.'s Q2 2024 Earnings (NASDAQ:JAKK)
marketbeat.com - April 17 at 5:24 PM
JAKKS Pacific (JAKK) Price Target Decreased by 7.32% to 38.76JAKKS Pacific (JAKK) Price Target Decreased by 7.32% to 38.76
msn.com - April 17 at 3:45 PM
Will Jakks Pacific (JAKK) Report Negative Earnings Next Week? What You Should KnowWill Jakks Pacific (JAKK) Report Negative Earnings Next Week? What You Should Know
zacks.com - April 17 at 11:06 AM
JAKKS Pacific (JAKK) Set to Announce Earnings on WednesdayJAKKS Pacific (JAKK) Set to Announce Earnings on Wednesday
americanbankingnews.com - April 17 at 3:10 AM
What Makes Jakks (JAKK) a New Strong Buy StockWhat Makes Jakks (JAKK) a New Strong Buy Stock
zacks.com - April 16 at 1:01 PM
Best Value Stocks to Buy for April 16thBest Value Stocks to Buy for April 16th
zacks.com - April 16 at 10:21 AM
JAKKS Pacific, Inc. Announces First Quarter 2024 Earnings CallJAKKS Pacific, Inc. Announces First Quarter 2024 Earnings Call
globenewswire.com - April 15 at 11:54 PM
JAKKS Pacific, Inc. (NASDAQ:JAKK) Short Interest Up 30.5% in MarchJAKKS Pacific, Inc. (NASDAQ:JAKK) Short Interest Up 30.5% in March
americanbankingnews.com - April 15 at 7:02 AM
JAKKS Pacific, Inc. (NASDAQ:JAKK) Short Interest UpdateJAKKS Pacific, Inc. (NASDAQ:JAKK) Short Interest Update
marketbeat.com - April 13 at 2:36 PM
Dragon Ball ZDragon Ball Z
kotaku.com - April 13 at 8:02 AM
Power RangersPower Rangers
kotaku.com - April 10 at 8:23 PM
Epic Story Media & JAKKS Pacific Team for Wild ManesEpic Story Media & JAKKS Pacific Team for Wild Manes
worldscreen.com - April 9 at 12:37 PM
JAKKS Pacific (JAKK) Unveils Partnership With Epic Story MediaJAKKS Pacific (JAKK) Unveils Partnership With Epic Story Media
zacks.com - April 9 at 12:06 PM
JAKKS Pacific, Epic Story Media to Launch Licensing Program for ‘Wild Manes’JAKKS Pacific, Epic Story Media to Launch Licensing Program for ‘Wild Manes’
toybook.com - April 8 at 4:34 PM

New MarketBeat Followers Over Time

Media Sentiment Over Time

Company Descriptions

Atai Life Sciences logo

Atai Life Sciences

NASDAQ:ATAI
ATAI Life Sciences N.V., a clinical-stage biopharmaceutical company, engages in acquiring, incubating, and developing various therapeutics to treat depression, anxiety, addiction, and other mental health disorders. Its principal clinical programs include RL-007, a pro-cognitive neuromodulator for cognitive impairment associated with schizophrenia; GRX-917, a deuterated etifoxine for anxiety disorders; VLS-01 a N,N-Dimethyltryptamine for treatment resistant depression (TRD); DMX-1002, an oral formulation of ibogaine, a cholinergic, glutamatergic and monoaminergic receptor modulator that is a naturally occurring psychedelic product isolated from a West African shrub for the treatment of opioid use disorders (OUD); and EMP-01, an oral formulation of an MDMA derivative being developed for the treatment of post-traumatic stress disorder. The company's other clinical programs comprise PCN-101, a subcutaneous formulation of R-ketamine, as a therapy for psychiatric indications initially focused on TRD; and KUR-101, a formulation of deuterated mitragynine for the treatment of OUD. ATAI Life Sciences N.V. was founded in 2018 and is headquartered in Berlin, Germany with offices in New York and London.
Charles & Colvard, Ltd. logo

Charles & Colvard, Ltd.

NASDAQ:CTHR
Charles & Colvard, Ltd. operates as a fine jewelry company in the United States and internationally. The company operates in two segments, Online Channels and Traditional. It manufactures, markets, and distributes moissanite jewels and finished moissanite jewelry under the Charles & Colvard Created Moissanite brand; and premium moissanite gemstones under the Forever One brand name. The company also markets and distributes lab grown diamonds and finished jewelry with lab grown diamonds under the Caydia brand. It sells its products at wholesale prices to distributors, manufacturers, retailers, and designers; and to end-consumers at retail prices through charlesandcolvard.com and moissaniteoutlet.com, third-party online marketplaces, drop-ship, and other e-commerce outlets, as well as through Charles & Colvard Signature Showroom and charlesandcolvarddirect.com for wholesale and retail customers. Charles & Colvard, Ltd. was incorporated in 1995 and is headquartered in Morrisville, North Carolina.
Emmis Communications logo

Emmis Communications

NASDAQ:EMMS
Emmis Communications Corporation, a diversified media company, engages in radio broadcasting activities in the United States. The company operates through two segments, Radio and Publishing. It operates 4 FM and 2 AM radio stations in New York and Indianapolis, as well as publishes Indianapolis Monthly magazine. The company also offers dynamic pricing consulting services; and sound masking solutions for offices and other commercial applications. Emmis Communications Corporation was founded in 1980 and is headquartered in Indianapolis, Indiana.
Galaxy Gaming logo

Galaxy Gaming

OTCMKTS:GLXZ
Galaxy Gaming, Inc., a gaming company, designs, develops, acquires, assembles, markets, and licenses proprietary casino table games and associated technology, platforms, and systems for the casino gaming industry. The company's proprietary table games comprise side bets, which are proprietary features and wagering options added to public domain games, such as baccarat, pai gow poker, craps, and blackjack table games under the Lucky Ladies, 21+3, Bonus Craps, and EZ Baccarat titles; and premium games, which are stand-alone games with their own set of rules and strategies under the Heads Up Hold 'em, High Card Flush, Cajun Stud, and Three Card Poker names. It also provides enhanced table systems, which include Bonus Jackpot System, an electronic system installed on gaming tables designed to collect data by detecting player wagers and other game activities. In addition, the company offers automated electronic tables and other ancillary equipment, as well as relicenses various game titles to operators of online gaming systems. It markets its products to online casinos worldwide; land-based casino gaming companies in North America, the Caribbean, Central America, the United Kingdom, Europe, and Africa; and cruise ship companies. The company was founded in 2006 and is headquartered in Las Vegas, Nevada.
JAKKS Pacific logo

JAKKS Pacific

NASDAQ:JAKK
JAKKS Pacific, Inc. designs, produces, markets, sells, and distributes toys and related products, electronic products, and other consumer products worldwide. It operates through two segments, Toys/Consumer Products and Costumes. The company offers action figures and accessories, such as licensed characters; toy vehicles and accessories; dolls and accessories, including small, large, fashion, and baby dolls based on licenses, as well as infant and pre-school products; private label products; and foot-to-floor ride-on products. The company also provides role play, dress-up, pretend play, and novelty products for boys and girls based on brands and entertainment properties, as well as on its own proprietary brands; and indoor and outdoor kids' furniture, activity trays and tables, room décor, and seasonal and outdoor products. In addition, it offers Halloween and everyday costumes for various ages based on licensed and proprietary non-licensed brands, and related Halloween accessories; outdoor activity toys; junior sports toys, including hyper-charged balls, sport sets, and toy hoops; and board games. The company sells its products through in-house sales staff and independent sales representatives to toy and mass-market retail chain stores, department stores, office supply stores, drug and grocery store chains, club stores, value-oriented dollar stores, toy specialty stores, and wholesalers. JAKKS Pacific, Inc. was incorporated in 1995 and is headquartered in Santa Monica, California.